Automation index

How much of a Immunologist’s job can AI already do?

An autoantibody panel comes earlier. Calling it autoimmune without leaving the patient untreated do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#178 / 703

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#127 / 703

In-house counsel

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contract, clauses and the risk. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Sales, the close and not yielding the essential. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Dispute, the procurator and not sleeping the deadline. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Board, the memo and not dressing it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The CEO, the rush and not signing blind. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Say no, and not leaving the company sold. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low